Patents by Inventor Kathy L. Rowlen

Kathy L. Rowlen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170115203
    Abstract: A method and a flow cytometer system in which a light path is aligned to optimally direct light from a light source to a flow cell of a flow cytometer instrument are provided. The flow cytometer may include an orientable mirror disposed in the light path between the light source and the flow cell. By changing an orientation of the mirror through a sequence of different orientations, an optimal orientation of the mirror may be determined, and the mirror may be oriented accordingly before proceeding to conduct a flow cytometry investigation.
    Type: Application
    Filed: June 2, 2015
    Publication date: April 27, 2017
    Inventors: Andrew W. SMOLAK, Erica Dawson TENENT, Kathy L. ROWLEN, Garrett S. WILSON, Christopher H. CONVERSE, Evan M. TOTH
  • Patent number: 9546936
    Abstract: In a method for processing biological materials for flow cytometry evaluation for virus particles, a mixture including biological material and purification particles is centrifuged to prepare a centrifuged composition including a supernatant that may be further processed prior to the flow cytometry evaluation. The purification particles include porous cores functionalized to capture smaller-size impurities in a biological material sample and a porous size-exclusion shell surrounding the core to exclude larger-size components of the biological material from entering into the core. Multiple samples may be processed in multi-sample processing units. A product may contain a sealed container with the unit quantity of purification particle in a storage liquid and a kit may include such a sealed container and a centrifugal filter.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: January 17, 2017
    Assignee: VIROCYT, INC.
    Inventors: Kathy L. Rowlen, Erica Dawson Tenent, Lauren R. Wolfe
  • Publication number: 20160076981
    Abstract: In a method for processing biological materials for flow cytometry evaluation for virus particles, a mixture including biological material and purification particles is centrifuged to prepare a centrifuged composition including a supernatant that may be further processed prior to the flow cytometry evaluation. The purification particles include porous cores functionalized to capture smaller-size impurities in a biological material sample and a porous size-exclusion shell surrounding the core to exclude larger-size components of the biological material from entering into the core. Multiple samples may be processed in multi-sample processing units. A product may contain a sealed container with the unit quantity of purification particle in a storage liquid and a kit may include such a sealed container and a centrifugal filter.
    Type: Application
    Filed: November 20, 2015
    Publication date: March 17, 2016
    Inventors: Kathy L. Rowlen, Erica Dawson Tenent, Lauren R. Wolfe
  • Publication number: 20150232911
    Abstract: In a method for processing biological materials for flow cytometry evaluation for virus particles, a mixture including biological material and purification particles is centrifuged to prepare a centrifuged composition including a supernatant that may be further processed prior to the flow cytometry evaluation. The purification particles include porous cores functionalized to capture smaller-size impurities in a biological material sample and a porous size-exclusion shell surrounding the core to exclude larger-size components of the biological material from entering into the core. Multiple samples may be processed in multi-sample processing units. A product may contain a sealed container with the unit quantity of purification particle in a storage liquid and a kit may include such a sealed container and a centrifugal filter.
    Type: Application
    Filed: June 26, 2014
    Publication date: August 20, 2015
    Inventors: Kathy L. Rowlen, Erica Dawson Tenent, Lauren R. Wolfe
  • Publication number: 20120316079
    Abstract: Methods for the quantification of influenza HA proteins and anti-influenza antibodies for the fields of vaccine-related protein quantification, potency determination, and efficacy evaluation are provided. According to the technology, quantification is achieved by providing capture agents attached to an array in a series of decreasing concentrations. Serial dilutions of a reference material also may be introduced. The reference material within each solution binds to the capture agents on the array and is labeled with a label agent capable of producing a detectable signal used to construct a calibration curve. A target material of unknown concentration is introduced to a separate identical array, and the target material binds to the capture agents and also is labeled by a label agent to produce a detectable signal. The calibration curve based on the reference material is then utilized to determine the concentration of the target material without the need to perform replicate experiments.
    Type: Application
    Filed: June 12, 2012
    Publication date: December 13, 2012
    Applicant: INDEVR, INC.
    Inventor: Kathy L. Rowlen
  • Publication number: 20110003308
    Abstract: There is described a new class or type of initiators for polymerization as a means of signal enhancement, nanoparticle initiators, and methods for amplifying signal resulting from recognition events, thereby enhancing the detection of those recognition events. Methods include amplification achieved through polymerization using a nanoparticle initiator conjugated recognition element that is not consumed during the reaction. The polymer formed as a result of the absorption of light by the nanoparticle initiator and introduction of reactive species into a surrounding polymerizable monomer solution occurs in a spatially-limited region directly surrounding the nanoparticle initiator and is indicative of the recognition event(s). In one embodiment, a semiconductor quantum dot nanoparticle initiator is utilized. In another embodiment, a metal nanoparticle is utilized. In another embodiment, the signal is detected without instrumentation.
    Type: Application
    Filed: March 18, 2009
    Publication date: January 6, 2011
    Applicant: INDEVR, INC.
    Inventors: Kathy L. Rowlen, Amber W. Taylor
  • Publication number: 20100273670
    Abstract: Embodiments of the present invention relate to compositions, methods and apparatus for detection of antiviral agent resistance or sensitivity of a virus. In some embodiments, antiviral agent resistance or sensitivity of influenza types, such as A, B and C may be identified. In more embodiments, sub-types such as the hemagglutinin (HA) and neuraminidase (NA) of influenza A may be analyzed for antiviral agent resistance or sensitivity. In a particular embodiment, the various strains of influenza virus may be analyzed for resistance or sensitivity using DNA microarray analysis designed to target a gene segment. In various embodiments, a microarray-based assay system with capture and detection (label) probes may be utilized to identify a change in a gene segment that confers resistance or sensitivity to an antiviral agent of an influenza strain.
    Type: Application
    Filed: August 21, 2007
    Publication date: October 28, 2010
    Inventors: Kathy L. Rowlen, Robert Kuchta, Michael Townsend, James Smagala, Erica Dawson
  • Publication number: 20100130378
    Abstract: Embodiments herein provide for methods, compositions and apparatus for detection and/or diagnosis of pathogenic virus lineage and/or strains. In some embodiments, the virus is influenza Type B virus. In other embodiments, an apparatus may include a microarray with attached capture probes, designed to bind to nucleic acid sequences from a single gene in a broad array of influenza strains. In some embodiments, compositions may include isolated nucleic acid sequences of use as capture probes, target sequences and/or label probe sequences, for diagnosis of and/or detection of influenza virus.
    Type: Application
    Filed: January 3, 2008
    Publication date: May 27, 2010
    Inventors: Kathy L. Rowlen, Daniela M. Mehlmann, Robert Kuchta, Martin Mehlmann, James Smagala, Chad Moore, Erica Dawson-Tenet, Nancy Cox, Michael W. Shaw
  • Publication number: 20090124512
    Abstract: Embodiments herein provide for methods, compositions and apparati for detection and/or diagnosis of virus types, subtypes and/or strains. In particular embodiments, the virus is an influenza virus. The apparatus may include a microarray with attached capture probes, designed to bind to oligonucleotides capable of binding at least a portion of a nucleic acid sequence of one or more target genes in a broad array of influenza types, subtypes or strains. The compositions may include isolated nucleic acids as capture probes, target sequences and/or tagged label probes, of use for diagnosis and/or detection of influenza virus.
    Type: Application
    Filed: January 18, 2007
    Publication date: May 14, 2009
    Applicant: REGENTS OF THE UNIVERSITY OF COLORADO
    Inventors: Kathy L. Rowlen, Robert Kuchta, Michael Townsend, James Smagala, Chad L. Moore, Erica Dawson, Martin Mehlmann, Nancy Cox, Catherine B. Smith, Daniela Mehlmann
  • Patent number: 7354706
    Abstract: The invention provides methods to detect molecular recognition events. The invention also provides methods to detect the presence of or identify a target species based on its interaction with one or more probe species. The methods of the invention are based on amplification of the signal due to each molecular recognition event. The amplification is achieved through photopolymerization, with the polymer formed being associated with the molecular recognition event. In an embodiment, a fluorescent polymer, a magnetic polymer, a radioactive polymer or an electrically conducting polymer can form the basis of detection and amplification. In another embodiment, a polymer gel swollen with a fluorescent solution, a magnetic solution, a radioactive solution or an electrically conducting solution can form the basis of detection and amplification. In another embodiment, sufficient polymer forms to be detectable by visual inspection.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: April 8, 2008
    Assignee: The Regents of The University of Colorado, a body corporate
    Inventors: Kathy L. Rowlen, John W. Birks, Christopher Bowman, Hadley Sikes, Ryan Hansen, Robert Kuchta
  • Patent number: 6377341
    Abstract: An apparatus and method for on-column analysis in flash chromatography. The detection scheme utilizes refractive index changes as analytes move through an illuminated region of a chromatography column. The column packing material is a diffuse scattering medium when the refractive index of the solvent is significantly different than that of the packing material. The magnitude of the signal depends on the degree to which the refractive index mismatch is changed as an analyte passes through the illuminated region. This detection scheme provides a simple, inexpensive means for monitoring the end of a flash chromatography column to determine the exit time of the species of interest, thus greatly reducing the post-column analysis time. Additionally, the detector is movable along the length of the column, offering the potential to monitor separations as they occur.
    Type: Grant
    Filed: August 3, 1999
    Date of Patent: April 23, 2002
    Assignee: University Technology Corporation
    Inventors: Kathy L. Rowlen, Sarah G. Westerbuhr